These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clinical management of snakebite envenoming: Future perspectives. Hamza M; Knudsen C; Gnanathasan CA; Monteiro W; Lewin MR; Laustsen AH; Habib AG Toxicon X; 2021 Sep; 11():100079. PubMed ID: 34430847 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria. Habib AG; Lamorde M; Dalhat MM; Habib ZG; Kuznik A PLoS Negl Trop Dis; 2015 Jan; 9(1):e3381. PubMed ID: 25569252 [TBL] [Abstract][Full Text] [Related]
9. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa. Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209 [TBL] [Abstract][Full Text] [Related]
10. Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease? Laustsen AH; Johansen KH; Engmark M; Andersen MR PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005361. PubMed ID: 28158193 [TBL] [Abstract][Full Text] [Related]
11. Antivenoms for the treatment of snakebite envenomings: the road ahead. Gutiérrez JM; León G; Burnouf T Biologicals; 2011 May; 39(3):129-42. PubMed ID: 21429763 [TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Next Generation Snakebite Antivenoms. Knudsen C; Laustsen AH Trop Med Infect Dis; 2018 Apr; 3(2):. PubMed ID: 30274438 [TBL] [Abstract][Full Text] [Related]
13. From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy. Laustsen AH; Engmark M; Milbo C; Johannesen J; Lomonte B; Gutiérrez JM; Lohse B Curr Pharm Des; 2016; 22(34):5270-5293. PubMed ID: 27339430 [TBL] [Abstract][Full Text] [Related]
14. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique. Guidolin FR; Caricati CP; Marcelino JR; da Silva WD PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709 [TBL] [Abstract][Full Text] [Related]
15. Bites and stings from venomous animals: a global overview. White J Ther Drug Monit; 2000 Feb; 22(1):65-8. PubMed ID: 10688262 [TBL] [Abstract][Full Text] [Related]
16. Current treatment for venom-induced consumption coagulopathy resulting from snakebite. Maduwage K; Isbister GK PLoS Negl Trop Dis; 2014 Oct; 8(10):e3220. PubMed ID: 25340841 [TBL] [Abstract][Full Text] [Related]
17. Neutralization capacity of recombinant antivenoms based on monoclonal antibodies and nanobodies. Ljungars A; Laustsen AH Toxicon; 2023 Jan; 222():106991. PubMed ID: 36481349 [No Abstract] [Full Text] [Related]
18. In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies. Laustsen AH; Karatt-Vellatt A; Masters EW; Arias AS; Pus U; Knudsen C; Oscoz S; Slavny P; Griffiths DT; Luther AM; Leah RA; Lindholm M; Lomonte B; Gutiérrez JM; McCafferty J Nat Commun; 2018 Oct; 9(1):3928. PubMed ID: 30279409 [TBL] [Abstract][Full Text] [Related]
19. Pitfalls to avoid when using phage display for snake toxins. Laustsen AH; Lauridsen LP; Lomonte B; Andersen MR; Lohse B Toxicon; 2017 Feb; 126():79-89. PubMed ID: 28017694 [TBL] [Abstract][Full Text] [Related]